AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -33% | -12.3% | 89.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69.2% | 68.1% | 62.8% | 44.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -827.1% | -623.2% | -377.5% | -860.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -860.2% | -667.7% | -392.8% | -937% |
| EPS Diluted | -54.18 | -176.53 | -143.99 | -205.96 |
| % Growth | 69.3% | -22.6% | 30.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |